CXCL13 and CXCL9 as diagnostic and therapy monitoring markers in central nervous system lymphoma

被引：0
|
作者：
Masouris, I. [1 ]
Pfirnnann, M. [2 ]
Manz, K. [2 ]
Koedeli, U. [1 ]
Von Baumgarten, L. [1 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Dept ofNeurol, Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Fac Med, Inst Med Informat Proc Biometry & Epidemiol, Munich, Germany
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR2209
引用
收藏
页码：392 / 392
页数：1
相关论文
共 50 条
  • [1] CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma-Diagnostic, Therapeutic, and Prognostic Relevance
    Masouris, Ilias
    Manz, Kirsi
    Pfirrmann, Markus
    Dreyling, Martin
    Angele, Barbara
    Straube, Andreas
    Langer, Sigrid
    Huber, Marion
    Koedel, Uwe
    Von Baumgarten, Louisa
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [2] CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients
    Fischer, Lars
    Korfel, Agnieszka
    Pfeiffer, Sebastian
    Kiewe, Philipp
    Volk, Hans-Dieter
    Cakiroglu, Huesniye
    Widmann, Thomas
    Thiel, Eckhard
    CLINICAL CANCER RESEARCH, 2009, 15 (19) : 5968 - 5973
  • [3] CXCL13 and CXCL12 in central nervous system (CNS) lymphoma patients
    Fischer, L.
    Korfel, A.
    Pfeiffer, S.
    Kiewe, P.
    Volk, H.
    Cakiroglu, H.
    Widmann, T.
    Thiel, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] The Role of CXCL13 and CXCL9 in Early Breast Cancer
    Razis, Evangelia
    Kalogeras, Konstantine T.
    Kotsantis, Ioannis
    Koliou, Georgia-Angeliki
    Manousou, Kyriaki
    Wirtz, Ralph
    Veltrup, Elke
    Patsea, Helen
    Poulakaki, Nikiforita
    Dionysopoulos, Dimitrios
    Pervana, Stavroula
    Gogas, Helen
    Koutras, Angelos
    Pentheroudakis, George
    Christodoulou, Christos
    Linardou, Helena
    Pavlakis, Kitty
    Koletsa, Triantafyllia
    Pectasides, Dimitrios
    Zagouri, Flora
    Fountzilas, George
    CLINICAL BREAST CANCER, 2020, 20 (01) : E36 - E53
  • [5] Role and application of chemokine CXCL13 in central nervous system lymphoma
    Li, Cuicui
    Zhang, Litian
    Jin, Qiqi
    Jiang, Haoyun
    Wu, Chongyang
    ANNALS OF HEMATOLOGY, 2024, 103 (08) : 2671 - 2680
  • [6] The potential for CXCL13 in CSF as a differential diagnostic tool in central nervous system infection
    Masouris, Ilias
    Klein, Matthias
    Koedel, Uwe
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (09) : 875 - 885
  • [7] THE ROLE OF CXCL9 AND CXCL13 IN PREDICTION OF POSTTRANSPLANT INFECTION IN KIDNEY TRANSPLANT RECIPIENTS
    Bai, Yangjuan
    Yan, Lin
    Li, Yi
    Li, Yamei
    Wang, Xianding
    Wang, Lanlan
    Shi, Yunying
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 2026 - 2026
  • [8] The role of CXCL9, CXCL10, and CXCL13 chemokines in patients with Sjögren's syndrome
    Hakbilen, Selda
    Tezcan, Dilek
    Onmaz, Duygu Eryavuz
    Yilmaz, Sema
    Korez, Muslu Kazim
    Unlu, Ali
    CLINICAL RHEUMATOLOGY, 2025, : 1635 - 1642
  • [9] Cerebrospinal fluid CXCL13 in non-borrelial central nervous system infections: contribution of CXCL13 to the differential diagnosis
    Smiskova, Dita
    Dzupova, Olga
    Moravcova, Lenka
    Picha, Dusan
    INFECTIOUS DISEASES, 2023, 55 (08) : 551 - 558
  • [10] The chemokines CXCL9 and CXCL13 as prognostic markers for metastasis and survival in rectal cancer patients after neoadjuvant chemoradiation.
    Sprenger, Thilo
    Behnes, Carl Ludwig
    Conradi, Lena-Christin
    Kauffels, Anne
    Wolff, Hendrik A.
    Ghadimi, Michael
    Liersch, Torsten
    Wirtz, Ralph M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
12345